Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation
Background & Aims: Cognitive dysfunction is an increasingly recognised manifestation of metabolic dysfunction-associated steatotic liver disease (MASLD), but the mechanistic link remains unclear. The aim of this study was to investigate the hypothesis that experimental MASLD leads to cogniti...
Main Authors: | Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M. Landau, Peter Lykke Eriksen, Stephen Hamilton-Dutoit, Nils Erik Magnusson, Majken Borup Thomsen, Fenghua Chen, Hendrik Vilstrup, Rajeshwar Prosad Mookerjee, Cecilie Bay-Richter, Karen Louise Thomsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555923003233 |
Similar Items
-
The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
by: Natasa Paklar, et al.
Published: (2023-11-01) -
Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease
by: Takao Miwa, et al.
Published: (2024-06-01) -
Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved
by: Peter Lykke Eriksen, et al.
Published: (2022-12-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
by: Wah-Kheong Chan, et al.
Published: (2023-09-01) -
Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose
by: Satoshi Shinozaki, et al.
Published: (2025-02-01)